|
|
Press Releases
9/2/10
Cerus and the Swiss Red Cross Report Successful Outcome of INTERCEPT Blood System Platelet Study
8/24/10
Cerus Signs Agreement to Acquire INTERCEPT Blood System Asian Commercial Rights from BioOne
7/29/10
Cerus Corporation Reports Second Quarter Revenues
7/12/10
Cerus to Release Second Quarter Results on July 29, 2010
6/30/10
Study Results Presented at International Transfusion Congress Highlight Cerus' Progress Toward Improving the Safety of Platelets, Plasma and Red Blood Cells
5/19/10
Cerus Appoints William "Obi" Greenman as Chief Business Officer
5/18/10
Whittemore Peterson Institute and Cerus Confirm Inactivation of XMRV by the INTERCEPT Blood System
4/29/10
Cerus Corporation Announces First Quarter 2010 Financial Results
4/7/10
Cerus to Release First Quarter Results on April 29, 2010
4/6/10
Cerus and Oxford Finance Corporation Enter into $10 Million Growth Capital Credit Facility
|
|
